[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (18,813)

Search Parameters:
Keywords = adhesion

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
24 pages, 1250 KiB  
Systematic Review
The Effect of Xanthine Oxidase Inhibitors in the Prevention and Treatment of Stroke: A Systematic Review and Meta-Analysis
by Lin Bai, Gerhard Litscher and Xiaoning Li
J. Cardiovasc. Dev. Dis. 2024, 11(12), 409; https://doi.org/10.3390/jcdd11120409 (registering DOI) - 21 Dec 2024
Abstract
Background: Xanthine oxidase inhibitors (XOIs) may help prevent stroke. However, heterogeneity can be found in the conclusions of different studies. The relevant evidence was summarized in this systematic review and meta-analysis to further clarify the role of XOIs in the prevention and treatment [...] Read more.
Background: Xanthine oxidase inhibitors (XOIs) may help prevent stroke. However, heterogeneity can be found in the conclusions of different studies. The relevant evidence was summarized in this systematic review and meta-analysis to further clarify the role of XOIs in the prevention and treatment of stroke, with a focus on evaluating the effects of XOIs in primary and secondary prevention of stroke, acute stroke treatment, and reduction of post-stroke complications. Methods: Randomized controlled trials (RCTs) or cohort studies on the effect of XOIs in the prevention and treatment of stroke were searched in PubMed, EMBASE, and Cochrane Library from inception to 3 March 2024, along with hand searching. The analyses were carried out using Review Manager 5.4. Results: The analysis included 14 studies (115,579 patients). While XOIs did not significantly reduce the risk of stroke (RR: 0.89; 95% CI: 0.59–1.34), they improved post-stroke functional outcomes, with a reduction in the modified Rankin scale scores (mean difference: −0.6; 95% CI: −0.8 to −0.4), decreased intercellular adhesion molecule-1 levels (mean difference: −15.2 ng/mL; 95% CI: −22.3 to −8.1), improved augmentation index (AIx) by 4.2% (95% CI: 2.5–5.9%), reduced central blood pressure (mean reduction: 4.8 mmHg; 95% CI: 2.6–6.9), and delayed carotid intima-media thickness progression (mean difference: −0.05 mm/year; 95% CI: −0.08 to −0.02). Full article
(This article belongs to the Special Issue Feature Review Papers in Stroke and Cerebrovascular Disease)
20 pages, 5318 KiB  
Review
Targeting Perineural Invasion in Pancreatic Cancer
by Ingrid Garajová and Elisa Giovannetti
Cancers 2024, 16(24), 4260; https://doi.org/10.3390/cancers16244260 (registering DOI) - 21 Dec 2024
Abstract
Pancreatic cancer is an aggressive tumor with dismal prognosis. Neural invasion is one of the pathological hallmarks of pancreatic cancer. Peripheral nerves can modulate the phenotype and behavior of the malignant cells, as well as of different components of the tumor microenvironment, and [...] Read more.
Pancreatic cancer is an aggressive tumor with dismal prognosis. Neural invasion is one of the pathological hallmarks of pancreatic cancer. Peripheral nerves can modulate the phenotype and behavior of the malignant cells, as well as of different components of the tumor microenvironment, and thus affect tumor growth and metastasis. From a clinical point of view, neural invasion is translated into intractable pain and represents a predictor of tumor recurrence and poor prognosis. Several molecules are implicated in neural invasion and pain onset in PDAC, including neutrophins (e.g., NGF), chemokines, adhesion factors, axon-guidance molecules, different proteins, and neurotransmitters. In this review, we discuss the role of nerves within the pancreatic cancer microenvironment, highlighting how infiltrating nerve fibers promote tumor progression and metastasis, while tumor cells, in turn, drive nerve outgrowth in a reciprocal interaction that fuels tumor advancement. We outline key molecules involved in neural invasion in pancreatic cancer and, finally, explore potential therapeutic strategies to target neural invasion, aiming to both inhibit cancer progression and alleviate cancer-associated pain. Full article
(This article belongs to the Special Issue Clinical Applications of Molecular Subtyping of Pancreatic Cancer)
Show Figures

Figure 1

Figure 1
<p>Innervation of pancreatic cancer. In pancreatic ductal adenocarcinoma, nerve fibers include axons originating from sympathetic and parasympathetic nerve fibers, sensory afferent nerve fibers, and also nerve fibers from the enteric nervous system. Neurotransmitters are released from parasympathetic fibers (ACH), sympathetic fibers (NE), sensory fibers (SP, CGRP), and enteric fibers (ACH, serotonin). Abbreviations: NE, noradrenaline; ACH, acetylcholine; SP, substance P; CGRP, calcitonin gene-related peptide. Created in BioRender. Garajova, I. (2024). <a href="https://BioRender.com/r29r619" target="_blank">https://BioRender.com/r29r619</a> (accessed on 11 December 2024).</p>
Full article ">Figure 2
<p>Tumor cells can be present in different spaces of the neuron sheath, including the endoneurium, perineurium, or epineurium. Created in BioRender. Garajova, I. (2024). <a href="https://BioRender.com/i31r247" target="_blank">https://BioRender.com/i31r247</a> (accessed on 11 December 2024).</p>
Full article ">Figure 3
<p>NGF/TrkA signaling pathway in PDAC. NGF acts on TrkA receptor and p75NTR receptors with subsequent activation of different signaling pathways. Abbreviations: TrkA, tropomyosin receptor kinase A; TrkB, tropomyosin receptor kinase B; TrkC, tropomyosin receptor kinase C; neurotrophin-3 (NT-3); neurotrophin-4/5 (NT-4/5); GDNF, glial-derived neurotrophic factor; NGF, nerve growth factor; MAPK, mitogen-activated protein kinase; PI3K, phosphatidylinositol-3-kinase; PLCγ, phospholipase Cγ; JNK, c-Jun N-terminal kinase; NF-κB, nuclear factor-κB; BDNF, brain-derived neurotrophic factor. Created in BioRender. Garajova, I. (2024). <a href="https://BioRender.com/s57o562" target="_blank">https://BioRender.com/s57o562</a> (accessed on 11 December 2024).</p>
Full article ">Figure 4
<p>Activation of TRPV1 in sensory nerves by NGF. TRPV1 is expressed by sensory afferents that have cell bodies in vagus nerve, trigeminal ganglia, and dorsal root ganglia. TRPV1 activation initiates downstream signaling of three major pathways including PI3K, TAK-1, and JAK signaling pathways. TRPV1 activation is required for release of neuropeptides such as SP and CGRP. Abbreviations: TRPV1, transient receptor potential vanilloid; PI3K, phosphatidylinositol-3-kinase; TAK-1, transforming growth factor-activated kinase 1; JAK, Janus kinase; SP, substance P; CGRP, calcitonin gene-related peptide. Created in BioRender. Garajova, I. (2024). <a href="https://BioRender.com/z29w911" target="_blank">https://BioRender.com/z29w911</a> (accessed on 11 December 2024).</p>
Full article ">Figure 5
<p>The nerves in the pancreatic cancer tumor microenvironment. The nerves influence other components of the tumor microenvironment, in particular cancer cells, immune cells, fibroblasts, and endothelial cells. Created in BioRender. Garajova, I. (2024). <a href="https://BioRender.com/k18n399" target="_blank">https://BioRender.com/k18n399</a> (accessed on 11 December 2024).</p>
Full article ">Figure 6
<p>Molecules involved in neural invasion. Several molecules are involved in neural invasion in PDAC, including neutrophins, adhesion factors, proteins, chemokines, axon-guidance molecules, neurotransmitters, and neuropeptides. Created in BioRender. Garajova, I. (2024). <a href="https://BioRender.com/k54v075" target="_blank">https://BioRender.com/k54v075</a> (accessed on 11 December 2024).</p>
Full article ">Figure 7
<p>Possibilities in NGF/TrkA signaling pathway inhibition. A possible site of NGF/TrkA inhibition: (1) NGF-capturing drugs. (2) Inhibitors of NGF binding to TrkA. (3) TrkA inhibitors. (4) Inhibitors of activated signaling pathways. Created in BioRender. Garajova, I. (2024). <a href="https://BioRender.com/f74a942" target="_blank">https://BioRender.com/f74a942</a> (accessed on 11 December 2024).</p>
Full article ">
26 pages, 1908 KiB  
Review
The MET Oncogene Network of Interacting Cell Surface Proteins
by Simona Gallo, Consolata Beatrice Folco and Tiziana Crepaldi
Int. J. Mol. Sci. 2024, 25(24), 13692; https://doi.org/10.3390/ijms252413692 (registering DOI) - 21 Dec 2024
Abstract
The MET oncogene, encoding the hepatocyte growth factor (HGF) receptor, plays a key role in tumorigenesis, invasion, and resistance to therapy, yet its full biological functions and activation mechanisms remain incompletely understood. A feature of MET is its extensive interaction network, encompassing the [...] Read more.
The MET oncogene, encoding the hepatocyte growth factor (HGF) receptor, plays a key role in tumorigenesis, invasion, and resistance to therapy, yet its full biological functions and activation mechanisms remain incompletely understood. A feature of MET is its extensive interaction network, encompassing the following: (i) receptor tyrosine kinases (RTKs); (ii) co-receptors (e.g., CDCP1, Neuropilin1); (iii) adhesion molecules (e.g., integrins, tetraspanins); (iv) proteases (e.g., ADAM10); and (v) other receptors (e.g., CD44, plexins, GPCRs, and NMDAR). These interactions dynamically modulate MET’s activation, signaling, intracellular trafficking, and degradation, enhancing its functional versatility and oncogenic potential. This review offers current knowledge on MET’s partnerships, focusing on their functional impact on signaling output, therapeutic resistance, and cellular behavior. Finally, we evaluate emerging combination therapies targeting MET and its interactors, highlighting their potential to overcome resistance and improve clinical outcomes. By exploring the complex interplay within the MET network of interacting cell surface proteins, this review provides insights into advancing anti-cancer strategies and understanding the broader implications of RTK crosstalk in oncology. Full article
(This article belongs to the Special Issue Latest Review Papers in Molecular and Cellular Biology 2024)
Show Figures

Figure 1

Figure 1
<p>Molecular structure of MET receptor and its natural ligand HGF. C-tail: C-terminal tail; ECD: extracellular domain; IPT: immunoglobulin–plexin–transcription factor domain; JM: juxta membrane domain; K1–K4: kringle domains; KD: kinase domain; N: N-terminal domain; PSI: plexin–semaphorin–integrin domain; SEMA: semaphorin-like domain; SPH: serine protease homology domain; TM: transmembrane domain. Inset: 2:2 MET-to-HGF active complex. Created in <a href="http://BioRender" target="_blank">BioRender</a> (accessed on 18 December 2024).</p>
Full article ">Figure 2
<p>Cell surface proteins interacting with MET: receptor tyrosine kinases and co-receptors. Created in <a href="http://BioRender" target="_blank">BioRender</a> (accessed on 18 December 2024).</p>
Full article ">Figure 3
<p>Cell surface proteins interacting with MET: Adhesion molecules (integrins, tetraspanins) and protease ADAM10. Created in <a href="http://BioRender" target="_blank">BioRender</a> (accessed on 18 December 2024).</p>
Full article ">Figure 4
<p>Other cell surface receptors interacting with MET: CD44, semaphorins and plexins, GPCRs, and NMDAR. Created in <a href="http://BioRender" target="_blank">BioRender</a> (accessed on 18 December 2024).</p>
Full article ">
17 pages, 8649 KiB  
Article
LPS Disrupts Endometrial Receptivity by Inhibiting STAT1 Phosphorylation in Sheep
by Xing Fan, Jinzi Wei, Yu Guo, Juan Ma, Meiyu Qi, He Huang, Peng Zheng, Wenjie Jiang and Yuchang Yao
Int. J. Mol. Sci. 2024, 25(24), 13673; https://doi.org/10.3390/ijms252413673 (registering DOI) - 21 Dec 2024
Abstract
Uterine infections reduce ruminant reproductive efficiency. Reproductive dysfunction caused by infusion of Gram-negative bacteria is characterized by the failure of embryo implantation and reduced conception rates. Lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria, is highly abortogenic. In this [...] Read more.
Uterine infections reduce ruminant reproductive efficiency. Reproductive dysfunction caused by infusion of Gram-negative bacteria is characterized by the failure of embryo implantation and reduced conception rates. Lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria, is highly abortogenic. In this study, the effects of LPS infusion on the endometrial receptivity of sheep were studied during three critical periods of embryo implantation. The results showed that LPS infusion on d12, d16, and d20 of pregnancy in vivo interfered with the expression of prostaglandins (PGs) and affected the expression of adhesion-related factors (ITGB1/3/5, SPP1), key implantation genes (HOXA10, HOXA11 and LIF), and progestational elongation genes (ISG15, RSAD2 and CXCL10) during embryo implantation. In addition, after LPS infusion on d12, d16, and d20, the phosphorylation level of STAT1 significantly decreased and the protein expression level of IRF9 significantly increased on d12, suggesting that LPS infusion in sheep impairs endometrial receptivity through the JAK2/STAT1 pathway. Sheep endometrial epithelial cells were treated with 17 β-estrogen, progesterone, and/or interferon-tau in vitro to mimic the receptivity of the endometrium during early pregnancy for validation. LPS and the p-STAT1 inhibitor fludarabine were both added to the model, which resulted in reduced p-STAT1 protein expression, significant inhibition of PGE2/PGF2α, and significant suppression of the expression of key embryo implantation genes. Collectively, these results indicate that LPS infusion in sheep on d12, d16, and d20 impairs endometrial receptivity through the JAK2/STAT1 pathway, which is responsible for LPS-associated pregnancy failure. Full article
(This article belongs to the Section Molecular Biology)
Show Figures

Figure 1

Figure 1
<p>Effect of LPS on prostaglandin expression in sheep endometrium. (<b>A</b>) The secretion of PGE2 and PGF2α in endometrial tissue was measured on d12, d16, and d20 of pregnancy using an ELISA kit. (<b>B</b>) The secretion of PGE2 and PGF2α in endometrial tissue was measured on d12, d16, and d20 of pregnancy using an ELISA kit. (<b>C</b>) The ratio of PGE2 and PGF2α in endometrial tissue on d12, d16, and d20 of pregnancy. (<b>D</b>) The rate-limiting enzymes <span class="html-italic">PTGS1</span>, <span class="html-italic">PTGS2</span> (<b>E</b>), <span class="html-italic">PTGES</span> (<b>F</b>), and <span class="html-italic">PGFS</span> (<b>G</b>) of synthesized PGs in endometrial tissue on d12, d16, and d20 of pregnancy were measured by real-time quantitative PCR. All data are presented as the mean ± SEM, <span class="html-italic">n</span> ≥ 3; * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 2
<p>Effect of LPS on endometrial receptivity genes in sheep. (<b>A</b>) The pro-conceptus elongation gene <span class="html-italic">ISG15</span>, <span class="html-italic">RSAD2</span> (<b>B</b>), and <span class="html-italic">CXCL10</span> (<b>C</b>) on d12, d16, and d20 of pregnancy in endometrial tissue were measured by real-time quantitative PCR. (<b>D</b>) The adhesion molecules <span class="html-italic">ITGB1</span>, <span class="html-italic">ITGB3</span> (<b>E</b>), <span class="html-italic">ITGB5</span> (<b>F</b>), <span class="html-italic">SPP1</span> (<b>G</b>), and <span class="html-italic">MUC1</span> (<b>H</b>) on d12 of pregnancy in endometrial tissue were measured by real-time quantitative PCR. (<b>I</b>) The endometrial receptivity markers <span class="html-italic">HOXA10</span>, <span class="html-italic">HOXA11</span> (<b>J</b>), and <span class="html-italic">LIF</span> (<b>K</b>) on d12 of pregnancy in endometrial tissue were measured by real-time quantitative PCR. All data are presented as the mean ± SEM, <span class="html-italic">n</span> ≥ 3; * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 3
<p>LPS affected JAK2/STAT1 pathways. (<b>A</b>) The protein level of p-JAK2, T-JAK2, p-STAT1, T-STAT1, and IRF9 on d12, d16, and d20 of pregnancy in sheep endometrial tissue. (<b>B</b>) p-JAK2/β-actin, T-JAK2/β-actin (<b>C</b>), and p-JAK2/T-JAK2 (<b>D</b>) ratio on d12, d16, and d20 of pregnancy in sheep endometrial tissue. (<b>E</b>) p-STAT1/β-actin, T-STAT1/β-actin (<b>F</b>), and p-STAT1/T-STAT1 (<b>G</b>) ratio on d12, d16, and d20 of pregnancy in sheep endometrial tissue. (<b>H</b>) The IRF9/β-actin ratio on d12, d16, and d20 of pregnancy in sheep endometrial tissue. All data are presented as the mean ± SEM, <span class="html-italic">n</span> ≥ 3; * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 4
<p>Establishment of a receptive sheep endometrial epithelial cell model for sheep. (<b>A</b>) Confocal microscopy was used to observe the morphology of sEECs. Red: Cy3-labeled cytokeratin 18 protein; blue, DAPI-labeled nuclei; scale bar: 20 µm. (<b>B</b>) Expression of ISG15 was measured under different concentrations in sEECs. (<b>C</b>–<b>E</b>) The endometrial receptivity-related genes <span class="html-italic">ISG15</span>, <span class="html-italic">RSAD2</span>, <span class="html-italic">CXCL10</span>, <span class="html-italic">HOXA10</span>, <span class="html-italic">HOXA11</span>, <span class="html-italic">LIF</span>, <span class="html-italic">ESR1</span>, <span class="html-italic">ESR2</span>, and <span class="html-italic">PGR</span> in sEECs were measured by real-time quantitative PCR. GAPDH (sheep) was used as the reference gene in all samples. sEECs: sheep endometrial epithelial cells. All data are presented as the mean ± SEM, <span class="html-italic">n</span> ≥ 3; * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 5
<p>Effect of LPS or fludarabine treatment on the expression of endometrial receptivity-related genes under hormone treatment. (<b>A</b>) The protein level of p-STAT1 and T-STAT1 in sEECs. (<b>B</b>) The secretion of PGE2 and PGF2α in sEECs. (<b>C</b>–<b>E</b>) The pro-conceptus elongation genes <span class="html-italic">ISG15</span>, <span class="html-italic">RSAD2</span>, <span class="html-italic">CXCL10</span>, adhesion molecules <span class="html-italic">ITGB1/3/5</span>, <span class="html-italic">MUC1</span>, <span class="html-italic">SPP1</span>, and receptivity markers <span class="html-italic">HOXA10</span>, <span class="html-italic">HOXA11</span>, <span class="html-italic">LIF</span> mRNA expression levels in sEECs. GAPDH (sheep) was used as the reference gene in all samples. (<b>F</b>) Confocal microscope images of SPP1 expression in four treatment groups. Red: Cy3-labeled SPP1 protein; blue, DAPI-labeled nuclei; scale bar: 20 µm. All data are presented as the mean ± SEM, <span class="html-italic">n</span> ≥ 3; * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 6
<p>Schematic characterization of the cellular mechanism of LPS infusion effects on endometrial receptivity in sheep during early pregnancy. LPS blocked the effect of IFN-τ in the three stages of sheep embryo implantation and impaired the endometrial receptivity, which is characterized by interfering with the secretion of prostaglandins, hindering the elongation of the conceptus, and reducing the adhesion of the embryo by inhibiting the phosphorylation of STAT1.</p>
Full article ">
17 pages, 1325 KiB  
Article
Effect of Aggregate Crystalline Surface Anisotropy on Asphalt–Aggregate Interface Interaction Based on Molecular Dynamics
by Jian Li and Liang He
Appl. Sci. 2024, 14(24), 11969; https://doi.org/10.3390/app142411969 (registering DOI) - 20 Dec 2024
Abstract
To investigate the influence of aggregate crystalline surface anisotropy on the interfacial effects and understand the bonding mechanisms, molecular dynamics simulations were employed to analyze the spatial distribution, diffusion, and adhesion properties of asphalt on typical acidic (α-quartz, SiO2) and weakly [...] Read more.
To investigate the influence of aggregate crystalline surface anisotropy on the interfacial effects and understand the bonding mechanisms, molecular dynamics simulations were employed to analyze the spatial distribution, diffusion, and adhesion properties of asphalt on typical acidic (α-quartz, SiO2) and weakly alkaline (calcite, CaCO3) aggregates. The results indicated that different types and crystalline surfaces of aggregates did not alter the distribution patterns of the asphalt components on their surfaces. However, the magnitude of the radial distribution function (RDF) varied with different crystalline surfaces, and a higher RDF value was correlated with better adhesion performance. Different diffusion behaviors were exhibited by asphalt molecules on different crystalline surfaces: slower diffusion was correlated with stronger adhesion and faster diffusion with weaker adhesion. The adhesion performance was significantly affected by the anisotropy of the aggregates. In the asphalt–SiO2 system, the van der Waals energy and surface atomic density were the major influencing factors, whereas, in the asphalt–CaCO3 system, the electrostatic energy was significantly influenced by ionic bonding. Overall, alkaline aggregates showed greater adhesion performance with asphalt than acidic aggregates. Full article
(This article belongs to the Special Issue Fracture Mechanics of Asphalt Pavement Materials and Structures)
19 pages, 1357 KiB  
Article
Effect of Sheep’s Whey Edible Coatings with a Bioprotective Culture, Kombucha Tea or Oregano Essential Oil on Cheese Characteristics
by Carlos D. Pereira, Hanna Varytskaya, Oliwia Łydzińska, Katarzyna Szkolnicka, David Gomes and Arona Pires
Foods 2024, 13(24), 4132; https://doi.org/10.3390/foods13244132 (registering DOI) - 20 Dec 2024
Abstract
Films and coatings based on biopolymers have been extensively studied in recent years since they have less impact on the environment, can be obtained from renewable sources, have good coating and film-forming capacity, are biodegradable and can have interesting nutritional properties. In the [...] Read more.
Films and coatings based on biopolymers have been extensively studied in recent years since they have less impact on the environment, can be obtained from renewable sources, have good coating and film-forming capacity, are biodegradable and can have interesting nutritional properties. In the present study, sheep’s cheese whey powder (SCWP) was used to produce edible cheese coatings. Six types of cheese samples were produced: without coating (CON); treated with natamycin (NAT); with SCWP coating without antimicrobials (WCO); with SCWP coating with a commercial bioprotective culture (WFQ); with SCWP coating with kombucha tea (WKO); and with SCWP coating with oregano essential oil (WEO). At the end of the ripening period, all the cheeses were classified as full-fat and semihard, according to the Portuguese standard. The higher hardness and adhesiveness values of samples CON, WFQ and WKO were in line with the lower moisture in defatted cheese observed in these samples, indicating that future work should address the improvement of water vapor barrier properties of the whey-based coating. The samples treated with natamycin and with oregano essential oil presented significantly lower values for hardness. Differences were also observed on titratable acidity and aw, both between samples and because of ripening time. The color parameters of cheese samples also presented differences, chiefly in the rind, but the highest differences observed resulted from ripening time rather than between samples. In all cases, the counts of lactobacilli and lactococci surpassed log 7 CFU/g by the end of ripening. Regarding yeast and mold counts, the samples CON and WCO presented the highest values by the end of the ripening period (>log 4 CFU/g), while sample NAT presented the lowest value (ca. log 3 CFU/g). Samples WFQ, WKO and WEO presented values which were ca. 0.5 log cycles lower than samples CON and WCO. Hence, the use of SCWP alongside bioprotective culture, kombucha tea or oregano essential oil had a positive impact in the reduction of mold counts on cheese surfaces. Future work should also evaluate the joint use of different antimicrobials. Full article
(This article belongs to the Special Issue Probiotics in the Dairy Product: Trends, Advances and Opportunities)
31 pages, 3824 KiB  
Article
Reversal of Endothelial Cell Anergy by T Cell-Engaging Bispecific Antibodies
by Márcia Gonçalves, Karsten M. Warwas, Marten Meyer, Reinhard Schwartz-Albiez, Nadja Bulbuc, Inka Zörnig, Dirk Jäger and Frank Momburg
Cancers 2024, 16(24), 4251; https://doi.org/10.3390/cancers16244251 - 20 Dec 2024
Abstract
Objectives: Reduced expression of adhesion molecules in tumor vasculature can limit infiltration of effector T cells. To improve T cell adhesion to tumor endothelial cell (EC) antigens and enhance transendothelial migration, we developed bispecific, T-cell engaging antibodies (bsAb) that activate T cells after [...] Read more.
Objectives: Reduced expression of adhesion molecules in tumor vasculature can limit infiltration of effector T cells. To improve T cell adhesion to tumor endothelial cell (EC) antigens and enhance transendothelial migration, we developed bispecific, T-cell engaging antibodies (bsAb) that activate T cells after cross-linking with EC cell surface antigens. Methods: Recombinant T-cell stimulatory anti-VEGFR2–anti-CD3 and costimulatory anti-TIE2–anti-CD28 or anti-PD-L1–anti-CD28 bsAb were engineered and expressed. Primary lines of human umbilical vein endothelial cells (HUVEC) that constitutively express VEGFR2 and TIE2 growth factor receptors and PD-L1, but very low levels of adhesion molecules, served as models for anergic tumor EC. Results: In cocultures with HUVEC, anti-VEGFR2–anti-CD3 bsAb increased T cell binding and elicited rapid T cell activation. The release of proinflammatory cytokines TNF-α, IFN-γ, and IL-6 was greatly augmented by the addition of anti-TIE2–anti-CD28 or anti-PD-L1–anti-CD28 costimulatory bsAb. Concomitantly, T cell-released cytokines upregulated E-selectin, ICAM1, and VCAM1 adhesion molecules on HUVEC. HUVEC cultured in breast cancer cell-conditioned medium to mimic the influence of tumor-secreted factors were similarly activated by T cell-engaging bsAb. Migration of T cells in transwell assays was significantly increased by anti-VEGFR2–anti-CD3 bsAb. The combination with costimulatory anti-TIE2–anti-CD28 bsAb augmented activation and proliferation of migrated T cells and their cytotoxic capacity against spheroids of the MCF-7 breast cancer cell line seeded in the lower transwell chamber. Conclusions: T cells activated by anti-VEGFR2–anti-CD3 and costimulatory EC-targeting bsAb can reverse the energy of quiescent EC in vitro, resulting in improved T cell migration through an EC layer. Full article
(This article belongs to the Section Cancer Immunology and Immunotherapy)
16 pages, 5381 KiB  
Article
First Record of a Rare New Species of Dracognomus (Nematoda: Draconematidae) from the Northwest Pacific Ocean
by Seungyeop Han and Hyun Soo Rho
Diversity 2024, 16(12), 776; https://doi.org/10.3390/d16120776 - 20 Dec 2024
Abstract
We report the discovery of a novel free-living marine nematode, Dracognomus elongatus sp. nov., from the genus Dracognomus Allen & Noffsinger, 1978 (Nematoda: Draconematidae), collected from geniculate coralline algal assemblages in the intertidal zone along the eastern coast of Korea in the Northwest [...] Read more.
We report the discovery of a novel free-living marine nematode, Dracognomus elongatus sp. nov., from the genus Dracognomus Allen & Noffsinger, 1978 (Nematoda: Draconematidae), collected from geniculate coralline algal assemblages in the intertidal zone along the eastern coast of Korea in the Northwest Pacific Ocean. Dracognomus elongatus sp. nov. is distinguished from its congeners by several key features: a relatively long body length (522 µm), densely developed minute spine-like ornamentation along the margins of body annules, small pore-shaped amphids (2 µm) with membranous tubes filled with corpus gelatum extending to the fifth body annule, twelve modified cephalic adhesion tubes located posterior to the rostrum, eight pairs of modified adhesion tubes in the mid-body region, an arrangement of both normal and modified subventral adhesion tubes (three pairs of each), disc-shaped tips on sublateral adhesion tubes, absence of copulatory thorns in males, and the presence of three pairs of short setae with no protuberances on the non-annulated tail end. Morphological details and illustrations were obtained using differential interference contrast microscopy. We also provide information on the geographic distribution and comparative characteristics of species within the genus Dracognomus, along with a schematic ventral view of a congener illustrating the arrangement of posterior adhesion tubes and copulatory thorns. Additionally, we present a species-level pictorial dichotomous key. Dracognomus elongatus sp. nov. is the eighth described species of this rare genus and marks the first record of Dracognomus in the Northwest Pacific Ocean. Full article
(This article belongs to the Special Issue Dynamics of Marine Communities)
Show Figures

Figure 1

Figure 1
<p><span class="html-italic">Dracognomus elongatus</span> sp. nov., holotype male. (<b>A</b>) Habitus, lateral view; (<b>B</b>) anterior body region showing amphid with membranous tube filled with corpus gelatum, cephalic adhesion tubes, and cuticle with minute spines; (<b>C</b>) non-annulated tail end; (<b>D</b>) copulatory apparatus; (<b>E</b>) subventral adhesion tube (normal type); (<b>F</b>) subventral adhesion tube (modified type); (<b>G</b>) sublateral adhesion tube (disc-shaped type). Scale bars: (<b>A</b>) 50 µm, (<b>B</b>–<b>G</b>) 10 µm.</p>
Full article ">Figure 2
<p><span class="html-italic">Dracognomus elongatus</span> sp. nov., DIC photomicrographs of holotype male. (<b>A</b>) Entire view of the body, lateral view; (<b>B</b>) head region with an amphidial fovea and the anterior body cuticles covered with minute spines; (<b>C</b>) non-annulated tail end; (<b>D</b>) spicule and gubernaculum; (<b>E</b>) subventral adhesion tubes (normal type); (<b>F</b>) subventral adhesion tubes (modified type); (<b>G</b>) sublateral adhesion tubes (disc-shaped type). Scale bars: (<b>A</b>), 20 µm, (<b>B</b>–<b>G</b>) 10 µm.</p>
Full article ">Figure 3
<p>Schematic ventral view of the genus <span class="html-italic">Dracognomus</span> Allen &amp; Noffsinger, 1978, illustrating the arrangement of posterior adhesion tubes and copulatory thorns (<span class="html-italic">D. tinae</span> is excluded due to insufficient description; the number and locations of tubes are inferred from the available figures and descriptions) [<a href="#B1-diversity-16-00776" class="html-bibr">1</a>,<a href="#B3-diversity-16-00776" class="html-bibr">3</a>,<a href="#B4-diversity-16-00776" class="html-bibr">4</a>,<a href="#B5-diversity-16-00776" class="html-bibr">5</a>,<a href="#B6-diversity-16-00776" class="html-bibr">6</a>].</p>
Full article ">Figure 4
<p>Pictorial dichotomous key for species identification within the genus <span class="html-italic">Dracognomus</span> [<a href="#B1-diversity-16-00776" class="html-bibr">1</a>,<a href="#B3-diversity-16-00776" class="html-bibr">3</a>,<a href="#B4-diversity-16-00776" class="html-bibr">4</a>,<a href="#B5-diversity-16-00776" class="html-bibr">5</a>,<a href="#B6-diversity-16-00776" class="html-bibr">6</a>,<a href="#B7-diversity-16-00776" class="html-bibr">7</a>].</p>
Full article ">Figure 5
<p>Biogeographical distribution of species in the genus <span class="html-italic">Dracognomus</span> (Scale bars: 20 µm) [<a href="#B1-diversity-16-00776" class="html-bibr">1</a>,<a href="#B3-diversity-16-00776" class="html-bibr">3</a>,<a href="#B4-diversity-16-00776" class="html-bibr">4</a>,<a href="#B5-diversity-16-00776" class="html-bibr">5</a>,<a href="#B6-diversity-16-00776" class="html-bibr">6</a>,<a href="#B7-diversity-16-00776" class="html-bibr">7</a>].</p>
Full article ">
13 pages, 1576 KiB  
Article
Increased Adhesiveness of Blood Cells Induced by Mercury Chloride: Protective Effect of Hydroxytyrosol
by Pasquale Perrone, Raquel Ortega-Luna, Caterina Manna, Ángeles Álvarez-Ribelles and Victor Collado-Diaz
Antioxidants 2024, 13(12), 1576; https://doi.org/10.3390/antiox13121576 - 20 Dec 2024
Abstract
Mercury (Hg) is a highly toxic environmental contaminant that can harm human health, ultimately leading to endothelial dysfunction. Hg toxicity is partially mediated by the exposure of the cell membrane’s surface of erythrocytes (RBCs) to phosphatidylserine (PS). In the context of these challenges, [...] Read more.
Mercury (Hg) is a highly toxic environmental contaminant that can harm human health, ultimately leading to endothelial dysfunction. Hg toxicity is partially mediated by the exposure of the cell membrane’s surface of erythrocytes (RBCs) to phosphatidylserine (PS). In the context of these challenges, hydroxytyrosol, a phenolic compound of olive oil, has the ability to mitigate the toxic effects of Hg. This study aims to analyze the effect of Hg on the adhesion of RBCs and polymorphonuclear cells (PMNs) to the vascular endothelium and the potential protective effect of hydroxytyrosol, as these interactions are crucial in the development of cardiovascular diseases (CVDs). RBCs, PMNs, and human vein endothelial cells (HUVECs) were treated with increasing concentrations of HgCl2 and, in some cases, with hydroxytyrosol, and their adhesion to HUVECs and the expression of adhesion molecules were subsequently analyzed. Our results demonstrate that HgCl2 significantly increases the adhesion of both RBCs (2.72 ± 0.48 S.E.M., p-value < 0.02) and PMNs (11.19 ± 1.96 S.E.M., p-value < 0.05) to HUVECs and that their adhesiveness is significantly reduced following treatment with hydroxytyrosol (RBCs, 1.2 ± 1.18 S.E.M., p-value < 0.02 and PMNs, 4.04 ± 1.35 S.E.M., p-value < 0.06). Interestingly, HgCl2 does not alter the expression of adhesion molecules on either HUVECs or RBCs, suggesting that reduced exposure to PS is a key factor in hydroxytyrosol protection against HgCl2-induced RBC adhesion to the endothelium. On the other hand, HgCl2 induces increased expression of several PMN adhesion molecules (CD11b 215.4 ± 30.83 S.E.M. p-value < 0.01), while hydroxytyrosol inhibits their expression (e.g., CD11b 149 ± 14.35 S.E.M., p-value < 0.03), which would seem to be the mechanism by which hydroxytyrosol restricts PMN–endothelium interactions. These results provide new insights into the molecular mechanisms through which hydroxytyrosol mitigates the harmful effects of Hg on cardiovascular health, highlighting its potential as a therapeutic agent that can reduce the cardiovascular risk related to heavy metal exposure. Full article
(This article belongs to the Special Issue Oxidative Stress in Hemoglobin and Red Blood Cells)
Show Figures

Figure 1

Figure 1
<p>Effects of HgCl<sub>2</sub> on RBCs or PMN–endothelial-cell interactions. RBCs (Red Blood Cells), PMNs (Polymorphonuclear cells), and/or HUVECs (Human Umbilical Vein Endothelial cells) were incubated (RBCs/PMNs for 4 h and HUVECs for 24 h) with HgCl<sub>2</sub> (5–20 µM) or a vehicle (DMSO). After assembling the flow chamber, we evaluated the interactions of RBCs (<b>A</b>) and PMNs [rolling velocity (<b>B</b>) or adhesion (<b>C</b>)] with HUVECs. Data are presented as the mean ± S.E.M. (<span class="html-italic">n</span> ≥ 4). * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 or *** <span class="html-italic">p</span> &lt; 0.001 indicate statistical significance vs. the corresponding value in the vehicle-treated group (ANOVA, followed by Newman–Keuls test).</p>
Full article ">Figure 2
<p>Effect of HgCl<sub>2</sub> on the expression of adhesion molecules in PMNs. PMNs (Polymorphonuclear cells) were treated (4 h) with HgCl<sub>2</sub> (1 µM, 5 µM, 10 µM, and 20 µM) or a vehicle and the expression of the adhesion molecules CD11b (<b>B</b>), CD62L (<b>C</b>), PSGL-1 (<b>D</b>), and CD11a (<b>E</b>) and of the extracellular side of the membrane phospholipid PS (<b>F</b>) was measured by flow cytometry following the gating strategy shown in (<b>A</b>). Fluorescence values are expressed as a percentage of median fluorescence intensities of the control cells (vehicle, dotted line). Data are presented as the mean ± S.E.M. (<span class="html-italic">n</span> ≥ 4). * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 or *** <span class="html-italic">p</span> &lt; 0.001 indicate statistical significance vs. the corresponding value in the vehicle-treated group (ANOVA followed by Newman–Keuls test). PSGL-1: P-selectin glycoprotein ligand-1.</p>
Full article ">Figure 3
<p>Protective effects of hydroxytyrosol on HgCl<sub>2</sub>-induced RBC or PMN adhesion to endothelial cells. RBCs (Red Blood Cells), PMNs (Polymorphonuclear cells), and/or HUVECs (Human Umbilical Vein Endothelial cells) were incubated (RBCs/PMNs for 4 h and HUVECs for 24 h) with HgCl<sub>2</sub> 20 µM) or a vehicle (DMSO). In some cases, cells were pretreated with hydroxytyrosol (HT) 20 µM 15 min prior to the HgCl<sub>2</sub> treatment. After assembling the flow chamber, we evaluated the interactions of RBCs (<b>A</b>) or PMNs [rolling velocity (<b>C</b>) or adhesion (<b>D</b>)] with HUVECs. (<b>B</b>,<b>E</b>) are representative images of RBC– and PMN–endothelial-cell interactions, respectively. Scale bar: 100 µm. Yellow arrows indicate RBC or PMN adhere to HUVECs. Data are presented as the mean ± S.E.M. (<span class="html-italic">n</span> ≥ 4). ** <span class="html-italic">p</span> &lt; 0.01 or *** <span class="html-italic">p</span> &lt; 0.001 indicate statistical significance vs. the corresponding value in the vehicle-treated group, while # <span class="html-italic">p</span> &lt; 0.05 or ## <span class="html-italic">p</span> &lt; 0.01 indicate statistical significance vs. the corresponding value in the HgCl<sub>2</sub>-treated group (ANOVA followed by Newman–Keuls test).</p>
Full article ">Figure 4
<p>Protective effects of hydroxytirosol on the expression of adhesion molecules in PMNs induced by HgCl<sub>2</sub>. PMNs (Polymorphonuclear cells) were treated (4 h) with HgCl<sub>2</sub> (1 µM, 5 µM, 10 µM, and 20 µM) or with a vehicle. In some cases, cells were pretreated with hydroxytyrosol (HT) 20 µM or 40 µM 15 min before the HgCl<sub>2</sub> treatment. Subsequently, the expression of the adhesion molecules CD11b (<b>A</b>), CD62L (<b>B</b>), PSGL-1 (<b>C</b>), and CD11a (<b>D</b>) and of the extracellular side of the membrane phospholipid PS (<b>E</b>) were measured by flow cytometry. Fluorescence values are expressed as a percentage of the median fluorescence intensities of the control cells (vehicle, dotted line). Data are presented as the mean ± S.E.M. (<span class="html-italic">n</span> ≥ 4). * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 indicate statistical significance vs. the corresponding value in the vehicle-treated group, while # <span class="html-italic">p</span> &lt; 0.05 or ## <span class="html-italic">p</span> &lt; 0.01 indicate statistical significance vs. the corresponding value in the HgCl<sub>2</sub>-treated group (ANOVA followed by Newman–Keuls test).</p>
Full article ">Figure 5
<p>Summary of the effects of HgCl<sub>2</sub> on the different cell types evaluated alongside the protective effects of hydroxytirosol.</p>
Full article ">
19 pages, 6832 KiB  
Article
Optimization and Standardization of Stable De-Epidermized Dermis (DED) Models for Functional Evaluation of Cutaneous Cell Therapies
by Xi Chen, Corinne Scaletta, Zhifeng Liao, Alexis Laurent, Lee Ann Applegate and Nathalie Hirt-Burri
Bioengineering 2024, 11(12), 1297; https://doi.org/10.3390/bioengineering11121297 - 20 Dec 2024
Abstract
The human skin is a remarkable organ capable of extensive regeneration, especially after severe injuries such as burns and related wounds. The de-epidermized dermis (DED) model has become a valuable in vitro tool for skin regeneration studies, particularly for testing the mechanism of [...] Read more.
The human skin is a remarkable organ capable of extensive regeneration, especially after severe injuries such as burns and related wounds. The de-epidermized dermis (DED) model has become a valuable in vitro tool for skin regeneration studies, particularly for testing the mechanism of action and the efficacy of clinical cutaneous cell therapies. To further improve the quality and robustness of these applications, our study focused on optimizing and standardizing DED tissue preparation and storage, enhancing its effectiveness for clinical testing. Therefore, we optimized the air-liquid interfacial culture medium composition by simplifying the historical formulation without compromising keratinocyte (therapeutic cell model) viability or proliferation. Furthermore, we investigated the impacts of adding burn wound exudates in the model by focusing on cell behavior for enhanced translational significance. The results revealed notable differences in keratinocyte adhesion and proliferation between burn wound exudates collected at the early stages and late stages of acute patient treatment, providing new information on a possible therapeutic window to apply cell therapies on burn patients. Generally, this study reported a robust method for the preclinical in vitro assessment of keratinocyte-based cutaneous cell therapies using DED models. Overall, the study underscored the importance of using in vitro models with enhanced translational relevance to better predict the clinical effects of cutaneous cell therapies in burn patient populations. Full article
(This article belongs to the Section Biomedical Engineering and Biomaterials)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>(<b>A</b>) Abdominal tissue was treated to remove the adipose tissue with surgical scissors and was cut into strips. (<b>B</b>) Tissue strips were transferred to 50 mL Falcon tubes, which were filled with NaCl 1 M. After a 24 h/37 °C incubation phase, the epidermis was separated from the dermis with forceps. Each tissue strip was then cut into individual samples of ~1.5 cm<sup>2</sup> and placed into Falcon tubes with 1× PBS + 1% P/S. The solution was changed 2–3 times before processing for long-term storage. (<b>C</b>) Description of the DED model with the air–liquid interface. A sterile perforated metal support was positioned at the bottom of a 6-well plate. The DED was first incubated in complete culture medium for at least 2 h and carefully transferred onto the support, papillary side up. Selected culture media (~4 mL/well) were added to ensure nutrient perfusion. A 6 mm glass insert was gently placed in the center of the DED, allowing for 100–200 µL of cell seeding. Constructs (i.e., DED + cells) were maintained for 4 days at 37 °C, 5% CO<sub>2</sub>. Then, the glass inserts were removed, and the constructs were incubated for 7 more days. Cellular presence and surface repartition were assessed by MTT staining of the whole construct and by H&amp;E staining of 7 µm histological sections. DED, de-epidermized dermis; PBS, phosphate-buffered saline; MTT, 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide.</p>
Full article ">Figure 2
<p>Macroscopic images of an MTT assay for whole DED tissue samples, where media combinations were compared. The top medium (T) was used to fill the glass insert positioned on the DED. The bottom medium (B) was the DED culture medium. (<b>A</b>) Serum-free medium on both top and bottom. (<b>B</b>) mGreen’s medium on the bottom, and serum-free medium on the top. (<b>C</b>) Control sample with PBS on the bottom and complete medium on the top. (<b>D</b>) Serum-free medium is on the bottom, with complete medium on the top. (<b>E</b>) mGreen’s medium on the bottom, with complete medium on the top. DED, de-epidermized dermis; MTT, 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide.</p>
Full article ">Figure 3
<p>The effect of the conservation temperature on DED prior to recellularization with HaCaT cells (i.e., with mGreen’s medium for the air–liquid culture) was evaluated by MTT staining and histological analysis of H&amp;E tissue sections. The MTT assay stains viable and metabolically active keratinocytes and reveals the cell distribution on the DED macroscopically. Histological H&amp;E staining allows for morphological analysis of the stratified epidermal layer with respect to cellular adhesion and migration within the dermal structure. The figure shows DED cross-sections embedded in paraffin, cut at 7 µm, and stained with H&amp;E. Storage was performed at (<b>A</b>) 4 °C for six weeks; (<b>B</b>) −20 °C for six weeks; (<b>C</b>) −80 °C for six weeks; (<b>D</b>) 4 °C for five years. (<b>E</b>) Control group with PBS alone and no nutritive media, stored at 4 °C for six weeks. Upper right corners = MTT staining in macroscopic imaging. Scale bars = 50 µm. DED, de-epidermized dermis; MTT, 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide; PBS, phosphate-buffered saline.</p>
Full article ">Figure 4
<p>Results of culture media composition screening. (<b>C</b>) Control group. (<b>1</b>–<b>10</b>) Medium formula N.1–N.10. (<b>G</b>) mGreen’s medium. DED was evaluated macroscopically by MTT and histological analysis of H&amp;E tissue sections. The MTT assay stains viable and metabolically active keratinocytes and reveals the cell distribution on the DED macroscopically. Histological H&amp;E staining allows for morphological analysis of the stratified epidermal layer with respect to cellular adhesion and migration within the dermal structure. H&amp;E results and MTT results (i.e., upper right corners). The absence of specific medium components is represented by dark gray highlighting. Scale bars = 100 µm. C, complete medium; CT, cholera toxin; E, EGF; EGF, epidermal growth factor; G, mGreen’s medium; H, hydrocortisone; I, insulin; MTT, 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide.</p>
Full article ">Figure 5
<p>Immunohistochemical analysis of collagen IV, laminin 1, and K14 on DED constructs maintained in mGreen’s medium and the new simplified medium N°8. (<b>A</b>) Control group. (<b>B</b>) New simplified medium N°8. (<b>C</b>) mGreen’s medium. (<b>D</b>) Human skin control group. Scale bars = 20 µm. DED, de-epidermized dermis.</p>
Full article ">Figure 6
<p>H&amp;E staining and immunohistochemical analysis of collagen IV, laminin 1, and K14 of the DED constructs maintained with different burn wound exudates. (<b>A</b>) Early collection exudate group. (<b>B</b>) Late collection exudate group. Upper right corners = macroscopic images of tissues stained with MTT. Scale bars = 20 µm. DED, de-epidermized dermis.</p>
Full article ">
21 pages, 7422 KiB  
Article
Isolation and Characterization of Antibodies Against Vascular Cell Adhesion Molecule-1 Reveals Putative Role for Ig-like Domains 2 and 3 in Cell-to-Cell Interaction
by Binura Perera, Yuao Wu, Jessica R. Pickett, Nadya Panagides, Francisca M. Barretto, Christian Fercher, David P. Sester, Martina L. Jones, Hang T. Ta and Lucia F. Zacchi
Int. J. Mol. Sci. 2024, 25(24), 13650; https://doi.org/10.3390/ijms252413650 - 20 Dec 2024
Abstract
The vascular cell adhesion molecule-1 (VCAM-1) plays an important role in inflammation, where it facilitates the recruitment of leukocytes to the inflamed area via leukocytes’ VLA-4 and endothelial cells’ VCAM-1 interaction. VCAM-1 expression is also upregulated in certain cancers. VCAM-1 has seven Ig-like [...] Read more.
The vascular cell adhesion molecule-1 (VCAM-1) plays an important role in inflammation, where it facilitates the recruitment of leukocytes to the inflamed area via leukocytes’ VLA-4 and endothelial cells’ VCAM-1 interaction. VCAM-1 expression is also upregulated in certain cancers. VCAM-1 has seven Ig-like domains, with domains 1 and 4 shown to be critical for VLA-4 binding. However, the specific functions of individual VCAM-1 Ig-like domains remain poorly understood. In this study, we identified single-chain variable fragment (scFv) antibodies targeting domains 2, 3, and 5 of VCAM-1, and investigated the ability of these antibodies to block VCAM-1-mediated cell adhesion to macrophages. We show that scFv antibodies against Ig-like domains 2 and 3 interfere with the ability of macrophages to bind endothelial cells, suggesting that these domains also play a role in facilitating this interaction. These results emphasize the need to more carefully study the role of each domain on VCAM-1 function and highlight the potential of targeting these VCAM-1 domains for more tailored therapeutic interventions in inflammatory diseases and cancer. Full article
(This article belongs to the Section Molecular Biology)
Show Figures

Figure 1

Figure 1
<p>Flow cytometry analysis of the phage pools showed enrichment of anti-VCAM-1 phages in the round 2 phage pool. CHO XL99 cells non-transfected (<b>A</b>–<b>C</b>) or transfected with pEGFP-N1-mVCAM-1 (<b>D</b>–<b>F</b>) were incubated with the Jones–Mahler human naïve phage library (JM library) (<b>A</b>,<b>D</b>), round 1 phage pool (<b>B</b>,<b>E</b>), or round 2 phage pool (<b>C</b>,<b>F</b>). The plots depict GFP expression (x-axis) vs. phage binding (y-axis).</p>
Full article ">Figure 2
<p>Monoclonal flow cytometry confirmed the positive phage clones bound to mVCAM-1. Positive phage clones from round 2 phage pool selected by whole-cell ELISA were tested for binding to mVCAM-1 by flow cytometry using CHO XL99 cells transfected with mVCAM-1-eGFP (red) or not (blue). Shown are the 8 unique clones selected (<b>A</b>) 1A9, (<b>B</b>) 1H3, (<b>C</b>) 2B9, (<b>D</b>) 2D3, (<b>E</b>) 2D8, (<b>F</b>) 2E2, (<b>G</b>) 2E6, and (<b>H</b>) and 3H4. The plots depict GFP expression (x-axis) vs. phage binding (y-axis).</p>
Full article ">Figure 3
<p>Purified scFv-LPETGs bind mVCAM-1. ExpiCHO cells transiently transfected with mVCAM-1-eGFP (red) or not (blue) were stained with purified scFv-LPETGs. The scFvs were detected with a mouse anti-HIS antibody and goat anti-mouse Dylight650. Shown are the 6 unique clones (<b>A</b>) 1A9, (<b>B</b>) 2D3, (<b>C</b>) 2D8, (<b>D</b>) 2E2, (<b>E</b>) 2E6, and (<b>F</b>) 3H4, and (<b>G</b>) anti-VCAM-1 CBL1300 as positive control. The plots depict GFP expression (x-axis) vs. antibody binding (y-axis).</p>
Full article ">Figure 4
<p>Ig-like domain mapping of the isolated antibodies. (<b>A</b>) Schematics of mVCAM-1 Ig-like domain deletion mutants used in this study. (<b>B</b>,<b>C</b>) Flow cytometry analysis of the binding of the commercial anti-mVCAM-1 antibody (CBL1300) (<b>B</b>,<b>C</b>), anti-FLAG (<b>B</b>), and our new full-length IgG2a reformatted antibodies (<b>C</b>) to cells transiently transfected with mVCAM-1-eGFP WT (with or without N-terminal FLAG) or FLAG-tagged Ig-like deletion constructs. Overall, VCAM-1 cell surface expression was determined using anti-FLAG antibody or anti-VCAM-1 CBL1300 antibody (<b>B</b>). CBL1300 required a different secondary antibody control than the FLAG antibody; therefore, results with its own secondary antibody-only control are also shown (<b>B</b>). (<b>C</b>) Table showing the normalized MFI values for each of the VCAM-1/antibody combinations (also see <a href="#app1-ijms-25-13650" class="html-app">Supplementary Figure S8</a>). The color scheme correlates with MFI value, with lighter colors indicating lower antibody binding and darker colors indicating higher antibody binding. On the right, a schematic representation of the mVCAM1 Ig-like domain structure shows the (tentative) binding location for the different antibodies tested in this study. Displayed is the average normalized MFI-Max-Min (mVCAM-1-eGFP-positive, antibody-positive cells normalized to MFI of the mVCAM-1-eGFP-negative, antibody-negative cells) from one experiment with 2 replicates. Schematics were created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>.</p>
Full article ">Figure 5
<p>Anti-VCAM-1 scFvs targeting Ig-like domains 2 or 3 significantly decrease macrophage attachment to endothelial cells. Representative images from brightfield and green fluorescence, as well as their merged counterparts, show the attachability of macrophage J774A.1 cells (green) to activated SVEC4-10 endothelial cells (EC) after treatment with our different antibodies and control antibodies (20 μg/mL). A non-antibody treatment and a random (non-VCAM-1 binder) scFv treatment were used as negative controls, while treatment with commercial full-length anti-mVCAM-1 (CBL1300) was used as positive control. Displayed is the average normalized MFI +/− SEM of two experiments with 4 (each data point shown with a circle) or 5 (each data point shown with an x) replicates each, n = 9. The data were normalized by dividing each individual replicate to the mean of the non scFv-treated control (EC + Macrophage) within each repeat. All statistical comparisons are to the EC + macrophage control (one-way ANOVA followed by post-hoc Tukey pairwise comparisons): * <span class="html-italic">p</span> &lt; 0.05, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001; n.s. not significant.</p>
Full article ">
17 pages, 5118 KiB  
Article
Microstructural Analysis of the Human Scapula: Mandibular Bone Tissue Engineering Perspectives
by Ilya L. Tsiklin, Denis S. Bezdenezhnych, Aleksei S. Mantsagov, Alexandr V. Kolsanov and Larisa T. Volova
J. Funct. Biomater. 2024, 15(12), 386; https://doi.org/10.3390/jfb15120386 - 20 Dec 2024
Abstract
Mandibular bone defect reconstruction remains a significant challenge for surgeons worldwide. Among multiple biodegradable biopolymers, allogeneic bone scaffolds derived from human sources have been used as an alternative to autologous bone grafts, providing optimal conditions for cell recruitment, adhesion, and proliferation and demonstrating [...] Read more.
Mandibular bone defect reconstruction remains a significant challenge for surgeons worldwide. Among multiple biodegradable biopolymers, allogeneic bone scaffolds derived from human sources have been used as an alternative to autologous bone grafts, providing optimal conditions for cell recruitment, adhesion, and proliferation and demonstrating significant osteogenic properties. This study aims to investigate the bone microstructure of the human scapula as a source for allogeneic bone scaffold fabrication for mandibular tissue engineering purposes. We created color-coded anatomical maps of the scapula and the mandible, reflecting the best anatomical and geometrical match. In this pilot study, we hypothesized a microstructural similarity of these bone structures and evaluated the human scapula’s bone tissue engineering potential for mandibular bone tissue engineering by focusing on the microstructural characteristics. Lyophilized human scapular and mandibular bioimplants were manufactured and sterilized. Experimental bone samples from the scapula’s acromion, coracoid, and lateral border from the mandibular condyle, mandibular angle, and mental protuberance were harvested and analyzed using micro-CT and quantitative morphometric analysis. This pilot study demonstrates significant microstructural qualitative and quantitative intra-group differences in the scapular and mandibular experimental bone samples harvested from the various anatomical regions. The revealed microstructural similarity of the human scapular and mandibular bone samples, to a certain extent, supports the stated hypothesis and, thus, allows us to suggest the human scapula as an alternative off-the-shelf allogeneic scaffold for mandibular reconstruction and bone tissue engineering applications. Full article
(This article belongs to the Special Issue Biomaterials in Bone Reconstruction)
Show Figures

Figure 1

Figure 1
<p>Lyophilized left scapula (<b>a</b>,<b>b</b>) bioimplant Lyoplast<sup>®</sup> ((<b>a</b>)—posterior view, (<b>b</b>)—lateral view: 1—scapular acromion process (SAP); 2—scapular coracoid process (SCP); 3—scapular lateral border (SLB)) and right hemimandible (<b>c</b>) bioimplant Lyoplast<sup>®</sup>: 1—mandibular condyle (MC); 2—mandibular angle (MA); 3—mental protuberance (MP).</p>
Full article ">Figure 2
<p>Anatomical mapping of the human scapula ((<b>a</b>)—posterior view; (<b>b</b>)—anterior view; 1—superior angle, 2—inferior angle, 3—lateral border, 4—coracoid process, 5—acromion, 6—glenoid) and the human mandible (<b>c</b>) with respective color-coded recipient zones: mandibular condyle (MC); mandibular angle (MA); mental protuberance (MP).</p>
Full article ">Figure 3
<p>Preparation of the experimental mandibular and scapular bone samples ((<b>a</b>)—mandibular condyle (MC), mandibular angle (MA), mental protuberance (MP); (<b>b</b>)—scapular coracoid process (SCP), scapular acromion process (SAP), scapular lateral border (SLB); (<b>c</b>)—trepan bur and harvested experimental bone sample)).</p>
Full article ">Figure 4
<p>Scapular bone samples’ image acquisition, volume rendering, and segmentation ((<b>a</b>,<b>d</b>)—SCP; (<b>b</b>,<b>e</b>)—SAP; (<b>c</b>,<b>f</b>)—SLB)).</p>
Full article ">Figure 5
<p>Mandibular bone samples’ image acquisition, volume rendering, and segmentation ((<b>a</b>,<b>d</b>)—SCP; (<b>b</b>,<b>e</b>)—SAP; (<b>c</b>,<b>f</b>)—SLB)).</p>
Full article ">Figure 6
<p>Comparative analysis of the trabecular and cortical bone morphometric parameters of the experimental scapular bone samples: (<b>a</b>) trabecular bone volumetric parameters; (<b>b</b>) trabecular bone connectivity parameters; (<b>c</b>) cortical bone parameters.</p>
Full article ">Figure 7
<p>Comparative analysis of the trabecular and cortical bone morphometric parameters of the experimental mandibular bone samples: (<b>a</b>) trabecular bone volumetric parameters; (<b>b</b>) trabecular bone connectivity parameters; (<b>c</b>) cortical bone parameters.</p>
Full article ">Figure 7 Cont.
<p>Comparative analysis of the trabecular and cortical bone morphometric parameters of the experimental mandibular bone samples: (<b>a</b>) trabecular bone volumetric parameters; (<b>b</b>) trabecular bone connectivity parameters; (<b>c</b>) cortical bone parameters.</p>
Full article ">
11 pages, 5116 KiB  
Communication
Enhanced Expression of N-Cadherin, but Not of E-Cadherin, in Cutaneous Squamous Cell Carcinoma in Comparison to Basal Cell Carcinoma
by Joanna Pogorzelska-Dyrbuś, Danuta Nowicka-Suszko, Aleksandra Piotrowska, Zdzisław Woźniak, Piotr Dzięgiel and Jacek C. Szepietowski
Cancers 2024, 16(24), 4247; https://doi.org/10.3390/cancers16244247 - 20 Dec 2024
Abstract
Background: Adhesion molecules including E-cadherin and N-cadherin have been proven to contribute to the carcinogenesis process. It has been demonstrated that an increased expression or appearance of N-cadherin, as well as a reduction in the expression of E-cadherin, are documented in many cancers, [...] Read more.
Background: Adhesion molecules including E-cadherin and N-cadherin have been proven to contribute to the carcinogenesis process. It has been demonstrated that an increased expression or appearance of N-cadherin, as well as a reduction in the expression of E-cadherin, are documented in many cancers, often leading to the loss of intercellular adhesion and acquisition of a more invasive or even metastatic mesenchymal phenotype. The aim of this study was to assess the expression of E-cadherin and N-cadherin, as well as markers of proliferation Ki67 in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Methods: A total of 123 tumor paraffin specimens, including 73 BCC and 50 SCC cases, were obtained from multiple anatomical locations. The expression of E-Cadherin and N-Cadherin, including the percentage of stained cells, was assessed using a four-grade scale, with Ki-67 assessed on the five-grade scale. Results: A significantly higher expression of N-cadherin was observed in SCC compared to BCC, with 14% of SCC cases having a more than 50% expression of N-cadherin, and 10% with 26–50% expression, in comparison with 2.7% and 8.2% in BCC, respectively (p < 0.001). No significant differences were observed with regard to E-cadherin expression between SCC and BCC. Conclusions: Our results suggest that N-cadherin expression might contribute to the acquisition of the mesenchymal phenotype, SCC, when compared with BCC, with a high expression of E-cadherin in both tumors explaining their overall low rate of metastases; however, further research on the role of adhesion molecules in these tumors is needed. Full article
(This article belongs to the Special Issue Advances in Skin Cancer: Diagnosis, Treatment and Prognosis)
Show Figures

Figure 1

Figure 1
<p>Levels of expression of N-cadherin (<b>A</b>) and E-cadherin (<b>B</b>) in BCC and SCC. Abbreviations: BCC—Basal cell carcinoma; SCC—squamous cell carcinoma.</p>
Full article ">Figure 2
<p>Representative patterns of N-cadherin staining of BCC in 200× (<b>A</b>) and 400× (<b>B</b>) magnification and of SCC in 200× (<b>C</b>) and 400× (<b>D</b>) magnification. Abbreviations: BCC—Basal cell carcinoma; SCC—squamous cell carcinoma.</p>
Full article ">Figure 3
<p>Representative patterns of E-cadherin staining of BCC in 200× (<b>A</b>) and 400× (<b>B</b>) magnification and of SCC in 200× (<b>C</b>) and 400× (<b>D</b>) magnification. Abbreviations: BCC—Basal cell carcinoma; SCC—squamous cell carcinoma.</p>
Full article ">Figure 4
<p>Representative patterns of Ki-67 staining of BCC in 200× (<b>A</b>) and 400× (<b>B</b>) magnification and of SCC in 200× (<b>C</b>) and 400× (<b>D</b>) magnification. Abbreviations: BCC—Basal cell carcinoma; SCC—squamous cell carcinoma.</p>
Full article ">Figure 5
<p>Levels of expression of Ki-67 in BCC and SCC. Abbreviations: BCC—Basal cell carcinoma; SCC—squamous cell carcinoma.</p>
Full article ">
37 pages, 8597 KiB  
Article
Evaluation and Characterization of Functionally Graded Adhesive Joints: Experimental and Numerical Analyses
by Yanan Zhang, Pedro Gálvez, Miguel Angel Martínez, Juana Abenojar and Magd Abdel Wahab
Polymers 2024, 16(24), 3561; https://doi.org/10.3390/polym16243561 - 20 Dec 2024
Abstract
Epoxy resins have exhibited exceptional performance in engineering applications, particularly as a replacement for traditional mechanical joints in adhesive bonding. This study evaluates the suitability of two innovative adhesives, SikaPower®-1511 and SikaPower®-1548, in various graded configurations. The thermal curing [...] Read more.
Epoxy resins have exhibited exceptional performance in engineering applications, particularly as a replacement for traditional mechanical joints in adhesive bonding. This study evaluates the suitability of two innovative adhesives, SikaPower®-1511 and SikaPower®-1548, in various graded configurations. The thermal curing behavior of the adhesives was analyzed using differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FTIR). Shear tests and finite element simulations were employed to investigate the strength performance and interfacial stress distribution of four adhesive configurations, including single and graded joints in single lap adhesive joints. The results show that SikaPower®-1548 reveals a slower heat-curing rate and achieves an average shear limit load of 9 MPa, outperforming the more rigid SikaPower®-1511, which reaches 4 MPa. Ultimate load predictions indicate that the shear strength of the 1511-1548-1511 graded configuration is slightly lower than that of SikaPower®-1511, with a decrease of 8.86%. In contrast, the 1548-1511-1548 configuration demonstrates a significant improvement, achieving a 32.20% increase in shear strength, along with a 13.12% reduction in peel stress field intensity at the interface end and a 12.21% reduction in shear stress field intensity. Overall, the experimental and simulation results highlight the significant advantages of graded joints over traditional single joints in alleviating stress concentrations and enhancing joint strength. Additionally, the research confirms the potential of epoxy resins in advanced engineering applications, providing a reliable theoretical foundation and technical guidance for the design of graded adhesives. Full article
(This article belongs to the Special Issue Epoxy Resin and Composites: Properties and Applications)
Show Figures

Figure 1

Figure 1
<p>Diagram of Research Implementation.</p>
Full article ">Figure 2
<p>(<b>a</b>) Teflon mold with samples in manufacturing process, (<b>b</b>) samples of adhesive SikaPower<sup>®</sup>-1511 and (<b>c</b>) samples of adhesive SikaPower<sup>®</sup>-1548.</p>
Full article ">Figure 3
<p>Assembly of square steel prisms for adhesive bonding. Area (1): adhesive zone. Prism (2): support. Red arrow: placement of steel shim to achieve 0.2 mm thickness. Prism (3): stabilizes the assembly.</p>
Full article ">Figure 4
<p>Curing curves at different rates for SikaPower<sup>®</sup>-1511.</p>
Full article ">Figure 5
<p>Degree of conversion curves at different rates for (<b>a</b>) SikaPower<sup>®</sup>-1511 and (<b>b</b>) SikaPower<sup>®</sup>-1548.</p>
Full article ">Figure 6
<p>Activation energy curves by MFK for SikaPower<sup>®</sup>-1511 and SikaPower<sup>®</sup>-1548.</p>
Full article ">Figure 7
<p>FTIR spectra for component A, component B and mixture for (<b>a</b>) SikaPower<sup>®</sup>-1511 and (<b>b</b>) SikaPower<sup>®</sup>-1548.</p>
Full article ">Figure 8
<p>FTIR spectra of SikaPower<sup>®</sup>-1548 and SikaPower<sup>®</sup>-1511 after 72 h of curing.</p>
Full article ">Figure 9
<p>Representative tensile stress curves for SikaPower<sup>®</sup>-1548 and SikaPower<sup>®</sup>-1511.</p>
Full article ">Figure 10
<p>Representative shear strength curves for SikaPower<sup>®</sup>-1548, SikaPower<sup>®</sup>-1511 and graduated joints, with SikaPower<sup>®</sup>-1548 on the edges (1548-1511-1548) and SikaPower<sup>®</sup>-1511 on the edges (1511-1548-1511).</p>
Full article ">Figure 11
<p>Geometry, dimensions, boundary, and loading conditions of the single lap joint. The adhesive is located in the gray area.</p>
Full article ">Figure 12
<p>Local mesh refinement of the bonding interface in the lap joint.</p>
Full article ">Figure 13
<p>Traditional single-lap joints and graduated adhesive joints.</p>
Full article ">Figure 14
<p>Convergence analysis of peel stress (σ<sub>y</sub>) near the adhesive interface endpoint using SikaPower<sup>®</sup>-1511 adhesive under Pressure = 2 MPa.</p>
Full article ">Figure 15
<p>Stress distribution at the adhesive interface and within the adhesive layer of SikaPower<sup>®</sup>-1511. (<b>a</b>) Peel stress distribution; (<b>b</b>) Shear stress distribution. The gray area indicates the location of the adhesive, it is marked with a green eclipse.</p>
Full article ">Figure 16
<p>The maximum principal stress distribution of SikaPower<sup>®</sup>-1511 adhesive.</p>
Full article ">Figure 17
<p>Stress distribution at the adhesive interface of different resin epoxy adhesive combinations under Pressure = 2 MPa. Peel stress (<math display="inline"><semantics> <mrow> <msub> <mrow> <mo mathvariant="normal">σ</mo> </mrow> <mrow> <mi mathvariant="normal">y</mi> </mrow> </msub> </mrow> </semantics></math>) for (<b>a</b>) 1511 and 1511-1548-1511 and (<b>b</b>) 1548 and 1548-1511-1548; Shear stress (τ) for (<b>c</b>) 1511 and 1511-1548-1511 and (<b>d</b>) 1548 and 1548-1511-1548.</p>
Full article ">Figure 18
<p>Stress distribution at the adhesive interface of different resin epoxy adhesive combinations under Pressure = Failure Strength. Peel stress (<math display="inline"><semantics> <mrow> <msub> <mrow> <mo mathvariant="normal">σ</mo> </mrow> <mrow> <mi mathvariant="normal">y</mi> </mrow> </msub> </mrow> </semantics></math>) for (<b>a</b>) 1511 and 1511-1548-1511 and (<b>b</b>) 1548 and 1548-1511-1548; Shear stress (τ) for (<b>c</b>) 1511 and 1511-1548-1511 and (<b>d</b>) 1548 and 1548-1511-1548.</p>
Full article ">Figure 19
<p>The stress redistribution under an increasing load of SikaPower<sup>®</sup>-1511 adhesive.</p>
Full article ">Figure 20
<p>The complex stress states near the two interface ends under critical damage conditions of SikaPower<sup>®</sup>-1548 adhesive. (<b>a</b>) Max Principal Stress. (<b>b</b>) Peel Stress <math display="inline"><semantics> <mrow> <msub> <mrow> <mo mathvariant="normal">σ</mo> </mrow> <mrow> <mi mathvariant="normal">y</mi> </mrow> </msub> </mrow> </semantics></math>(<math display="inline"><semantics> <mrow> <msub> <mrow> <mi mathvariant="normal">S</mi> </mrow> <mrow> <mn>22</mn> </mrow> </msub> </mrow> </semantics></math>). (<b>c</b>) Shear Stress <math display="inline"><semantics> <mrow> <msub> <mrow> <mo mathvariant="normal">τ</mo> </mrow> <mrow> <mi>xy</mi> </mrow> </msub> </mrow> </semantics></math>(<math display="inline"><semantics> <mrow> <msub> <mrow> <mi mathvariant="normal">S</mi> </mrow> <mrow> <mn>12</mn> </mrow> </msub> </mrow> </semantics></math>).</p>
Full article ">Figure 21
<p>Shear stress distribution at the adhesive middle line of different resin epoxy adhesive combinations under Pressure = 2 MPa for (<b>a</b>) 1511 and 1511-1548-1511 and (<b>b</b>) 1548 and 1548-1511-1548;.and under Pressure = Failure Strength for (<b>c</b>) 1511 and 1511-1548-1511 and (<b>d</b>) 1548 and 1548-1511-1548.</p>
Full article ">Figure 22
<p>Max Principal Stress distribution of 1548-1511-1548 adhesive combinations under Pressure = Failure Strength. (<b>a</b>) at the adhesive ends. (<b>b</b>) at the second dangerous positions.</p>
Full article ">
25 pages, 8116 KiB  
Article
Study on Structural Fire Protection and Fire Resistance of Glued Laminated Timber Columns
by Dmitrii A. Korolchenko and Fedor A. Portnov
Buildings 2024, 14(12), 4049; https://doi.org/10.3390/buildings14124049 - 20 Dec 2024
Abstract
Glued wood is one of the most commonly used materials made of wood. Glued wood has many advantages related to its strength characteristics and operation. Nevertheless, due to the use of an adhesive base, it becomes necessary to carefully approach the issue of [...] Read more.
Glued wood is one of the most commonly used materials made of wood. Glued wood has many advantages related to its strength characteristics and operation. Nevertheless, due to the use of an adhesive base, it becomes necessary to carefully approach the issue of the fire resistance of building structures made of glued wood. The purpose of this study was to assess the effect of structural fire protection on the fire resistance of glued laminated timber columns; the task of developing methods for experimental and analytical assessments of the fire resistance of glued laminated timber columns, with the possibility of assessing the temperature of the wood under a layer of fire protection, was set, and an analysis of the effectiveness of these methods for assessing the fire resistance of such structures was conducted. The experimental assessment of fire resistance was based on the combined effects of fire and force on structures. The analytical assessment of the fire resistance was carried out using two methods, each of which estimated the time of the beginning of the ignition of the wood, as well as its combustion before the limit state of the structure was reached, but did not ascertain the acting force. As a result of evaluating the effect of structural fire protection on the fire resistance of glued wood columns, data on the heating of wood under a layer of fire protection were obtained, and the relationship between the deformation of the sample and the heating of the layers of fire protection was revealed, consisting of an increase in the ignition time of the wood with an increase in the thickness of the fire protection. Full article
(This article belongs to the Collection Buildings and Fire Safety)
Show Figures

Figure 1

Figure 1
<p>Columns made of glued laminated timber.</p>
Full article ">Figure 2
<p>A damaged timber house on fire in Novy Urengoy town.</p>
Full article ">Figure 3
<p>Flow chart of the research project.</p>
Full article ">Figure 4
<p>Horizontal fire resistance test furnace.</p>
Full article ">Figure 5
<p>The volume-average temperature (<span class="html-italic">T<sub>real</sub></span>) in the furnace fire chamber versus the time of thermal exposure of the specimens (<span class="html-italic">τ</span>).</p>
Full article ">Figure 6
<p>Layout of thermoelectric converters attached to specimens 1–2 (no fireproofing): 1—thermoelectric converter on surface.</p>
Full article ">Figure 7
<p>Layout of thermoelectric converters attached to specimens 3–4 (Fireproofing Option 1): 1—thermoelectric converter on wood surface; 2–4—thermoelectric converters on fireproof surface.</p>
Full article ">Figure 8
<p>Layout of thermoelectric converters attached to specimens 5–6 (Fireproofing Option 2): 1—thermoelectric converter on wood surface; 2–4—thermoelectric converters on fireproof surface.</p>
Full article ">Figure 9
<p>Strains of the specimens versus the time of thermal exposure.</p>
Full article ">Figure 10
<p>Strain rates of the specimens versus the time of thermal exposure.</p>
Full article ">Figure 11
<p>Temperatures (<span class="html-italic">T</span><sub>1</sub>, <span class="html-italic">T</span><sub>2</sub>, <span class="html-italic">T</span><sub>3</sub>, <span class="html-italic">T</span><sub>4</sub>) measured using the thermocouples (TEC1-TEC4) attached to the unheated surface of Specimen 3 versus the time of thermal exposure of Specimen 3 (<span class="html-italic">τ</span>).</p>
Full article ">Figure 12
<p>Temperatures (<span class="html-italic">T</span><sub>1</sub>, <span class="html-italic">T</span><sub>2</sub>, <span class="html-italic">T</span><sub>3</sub>, <span class="html-italic">T</span><sub>4</sub>) measured using the thermocouples (TEC1-TEC4) attached to the unheated surface of Specimen 4 versus the time of thermal exposure of Specimen 4 (<span class="html-italic">τ</span>).</p>
Full article ">Figure 13
<p>Temperatures (<span class="html-italic">T</span><sub>1</sub>, <span class="html-italic">T</span><sub>2</sub>, <span class="html-italic">T</span><sub>3</sub>, <span class="html-italic">T</span><sub>4</sub>) measured using the thermocouples (TEC1-TEC4) attached to the unheated surface of Specimen 5 versus the time of thermal exposure of Specimen 5 (<span class="html-italic">τ</span>).</p>
Full article ">Figure 14
<p>Temperatures (<span class="html-italic">T</span><sub>1</sub>, <span class="html-italic">T</span><sub>2</sub>, <span class="html-italic">T</span><sub>3</sub>, <span class="html-italic">T</span><sub>4</sub>) measured using the thermocouples (TEC1-TEC4) attached to the unheated surface of Specimen 6 versus the time of thermal exposure of Specimen 6 (<span class="html-italic">τ</span>).</p>
Full article ">Figure 15
<p>Photograph of Specimen 3 before the thermal exposure.</p>
Full article ">Figure 16
<p>Photograph of Specimen 3 after the thermal exposure.</p>
Full article ">Figure 17
<p>Photograph of Specimen 6 before the thermal exposure.</p>
Full article ">Figure 18
<p>Photograph of Specimen 6 after the thermal exposure.</p>
Full article ">Figure 19
<p>Heat transfer for Fireproofing Option 1 before and after thermal exposure: (1) before thermal exposure; (2) 30 min after the onset of thermal exposure; (3) 60 min after the onset of thermal exposure; and (4) 90 min after the onset of thermal exposure.</p>
Full article ">Figure 20
<p>Heat transfer for Fireproofing Option 2 before and after thermal exposure: (1) before thermal exposure; (2) 30 min after the onset of thermal exposure; (3) 60 min after the onset of thermal exposure; and (4) 90 min after the onset of thermal exposure.</p>
Full article ">
Back to TopTop